Desq Long
Sign in

Company

X4 Pharmaceuticals, Inc

XFOR · CIK 0001501697

SEC FORM 4
$11,883.64

X4 Pharmaceuticals, Inc (XFOR)

Purchase of 4,600 shares at $2.5834 per share.

Reporting Person Craig Adam R · Officer Title Executive Chairman · Transaction Code P

Traded Oct 16, 2026 · Disclosed Oct 19, 2026

Source: SEC Form 4 · 0001339498-26-000005 · filed 2026-10-19 · View filing →

SEC FORM 4
$33,658.33

X4 Pharmaceuticals, Inc (XFOR)

Sale of 11,767 shares at $2.8604 per share.

Reporting Person KIRSKE DAVID · Officer Title Chief Financial Officer · Transaction Code S

Traded Oct 1, 2026 · Disclosed Oct 5, 2026

Source: SEC Form 4 · 0001501697-26-000078 · filed 2026-10-05 · View filing →

SEC FORM 4
$210,829.30

X4 Pharmaceuticals, Inc (XFOR)

Sale of 47,436 shares at $4.4445 per share.

Reporting Person Craig Adam R · Officer Title Executive Chairman · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001501697-26-000069 · filed 2026-08-13 · View filing →

SEC FORM 4
$109,228.03

X4 Pharmaceuticals, Inc (XFOR)

Sale of 24,576 shares at $4.4445 per share.

Reporting Person Volpone John · Officer Title President · Transaction Code S

Traded Aug 12, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001501697-26-000070 · filed 2026-08-13 · View filing →